Pharmaceutical giant Bayer has won a patent battle against South African retailer Clicks, preventing the sale of a generic blood thinning medication. This decision raises concerns about the affordability of essential medicines for the public. Pharmaceutical giant Bayer has won a patent battle against South African retailer Clicks, preventing the sale of a generic blood thinning medication. This decision raises concerns about the affordability of essential medicines for the public.
